dpp 4 inhibitor and glp 1 receptor agonist combination The effect of DPP-4 inhibitors, GLP-1 agonists SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology GLP-1-RA and DPP-4 inhibitors in

N Engl J Med 381(9):841851 Bethel MA, Mentz RJ, Merrill P, Buse JB, Chan JC, Goodman SG et al (2018) Renal outcomes in the EXenatide study of cardiovascular event lowering (EXSCEL)

GLP-1s on their own have a low risk of hypoglycemia

doi: 10.1016/j.ejphar.2020.173581 82 TeramotoSMiyamotoNYatomiKTanakaYOishiHAraiHet al

Appetite Suppressants

We reviewed available literature of dietary supplementation interventions among individuals with obesity, weight loss clinical trials, and adiposity-related complications to help guide clinicians on potentially advantageous supplementation

Individuals with type 2 diabetes typically experience an impaired incretin effect, though GLP-1 secretion itself may be normal, slightly reduced, or context-dependent